Delivery Order SPE2DB20D3103-SPE2DB25FQ3E8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $1,686.07. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a competitively awarded, non-set-aside procurement. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the...
- The Defense Logistics Agency awarded a $1,997.24 delivery order to AmerisourceBergen Drug Corp for Adderall XR 10 mg capsules (100-count units) on August 4, 2025, with completion targeted for August 5, 2025. This firm fixed-price contract, issued without set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contractor, headquartered in Conshohocken, Pennsylvania, serves as a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 21, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a contract ceiling value of $1,040.94. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of April 22, 2025. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 11, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) valued at $1,721.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competitive procurement. The contract's place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 13, 2025, for the supply of Adderall XR 25 mg capsules (100-count units) valued at $1,828.72. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is expected to be completed by September 15, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $1,149.20. This non-set-aside award is scheduled for completion by September 10, 2025, with performance taking place at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of the company's substantial...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract value of $1,765.86. This firm fixed-price delivery order, with an ultimate completion date of August 29, 2025, represents a non-competitive set-aside delivery against AmerisourceBergen's larger pharmaceutical supply contract vehicle. The place of performance is listed as Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency awarded a $5,384.37 delivery order to AmerisourceBergen Drug Corp on July 31, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This firm fixed-price contract, with an ultimate completion date of August 1, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was made on a competitive, non-set-aside basis and will be performed at the vendor's corporate office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,388.24 for 100 capsules of Adderall XR 30 mg on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed-price pricing and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction within AmerisourceBergen Drug Corp's larger contractual...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $3,030.56. This competitive award, executed on September 5, 2025, with an ultimate completion date of September 8, 2025, represents a firm fixed-price delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is listed as Conshohocken, Pennsylvania,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FQ3E8Delivery Order
The Defense Logistics Agency awarded a $1,917.24 delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Adderall XR 10 mg capsules (100-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 17, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support to military and federal healthcare systems globally, encompassing a wide range of brand-name and generic medications, vaccines, and medical supplies across multiple therapeutic domains. AmerisourceBergen's consistent receipt of competitive awards for federal medical procurement—including various controlled substances and specialized medications—demonstrates its established capability as a critical pharmaceutical vendor for Defense Health Agency, U.S. Coast Guard, and other government healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/16/25 |